OSE Immunotherapeutics Stock
Stocks
OSE
FR0012127173
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Euronext Paris
19:55:00 17/08/2026 +04
|
After hours 21:41:08 | |||
| 3.350 EUR | +0.96% |
|
3.348 | -0.06% |
| 06-11 | OSE Immunotherapeutics Recovers Following Oddo BHF Endorsement |  |
| 06-10 | OSE Immunotherapeutics SA - Special Call |
| Market Cap | 78.04M 90.4M 73.21M 66.68M 125M 8.64B 127M 858M 336M 4.33B 339M 332M 14.4B | P/E 2026 * |
-2.55x | P/E 2027 * | -2.92x |
|---|---|---|---|---|---|
| Enterprise Value | 119M 138M 111M 102M 191M 13.16B 194M 1.31B 512M 6.59B 517M 506M 21.93B | EV / Sales 2026 * |
24.3x | EV / Sales 2027 * | 13.4x |
| Free-Float |
78.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: OSE Immunotherapeutics
| 1 day | +0.96% | ||
| 1 week | +3.72% | ||
| Current month | +4.49% | ||
| 1 month | +3.97% | ||
| 3 months | -34.82% | ||
| 6 months | -22.99% | ||
| Current year | -34.95% |
| 1 week | 3.19 |  | 3.54 |
| 1 month | 3.13 | | 3.54 |
| Current year | 2.87 | | 5.9 |
| 1 year | 2.87 | | 7.7 |
| 3 years | 2.7 | | 11.58 |
| 5 years | 2.7 | | 13.68 |
| 10 years | 2.7 | | 15.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Bozec
CEO | Chief Executive Officer | - | 02/10/2025 |
Thomas Gidoin
DFI | Director of Finance/CFO | 43 | 20/08/2025 |
Silvia Comis
CTO | Chief Tech/Sci/R&D Officer | - | 20/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Maryvonne Hiance
BRD | Director/Board Member | 77 | 31/05/2016 |
Brigitte Dreno
BRD | Director/Board Member | 73 | 14/06/2017 |
| Director/Board Member | - | 22/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/11/24 | Sell | Director | 30,000 | 0.1375% | ||
| 12/11/24 | Sell | Chief Administrative Officer | 10,000 | 0.0458% | ||
| 21/06/24 | Fiscal year | Director | 10,000 | 0.0459% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.96% | +3.72% | -51.48% | +20.07% | 90.35M | |
| +0.68% | -2.28% | +1.91% | +19.70% | 48.42B | |
| +5.11% | +3.08% | +485.32% | +628.41% | 43.66B | |
| +3.73% | +0.47% | +12.95% | +87.58% | 39.51B | |
| +1.36% | -1.30% | +24.05% | +11.50% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +58.18% | 32.61B | |
| +0.08% | -2.52% | - | - | 16.32B | |
| +2.40% | -1.94% | +27.62% | +132.95% | 16.15B | |
| -0.62% | -0.06% | +3.95% | +27.74% | 14.16B | |
| +2.91% | +3.92% | +83.38% | +44.03% | 13.37B | |
| Average | +1.56% | -0.35% | +67.59% | +114.46% | 26.32B | |
| Weighted average by Cap. | +1.90% | -0.62% | +101.31% | +151.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.9M 5.68M 4.6M 4.19M 7.87M 543M 7.98M 53.89M 21.12M 272M 21.31M 20.85M 904M | 10.53M 12.2M 9.88M 9M 16.92M 1.17B 17.15M 116M 45.38M 584M 45.79M 44.8M 1.94B |
| Net income | -30.59M -35.43M -28.69M -26.14M -49.14M -3.39B -49.82M -336M -132M -1.7B -133M -130M -5.65B | -21.47M -24.87M -20.14M -18.34M -34.49M -2.38B -34.97M -236M -92.51M -1.19B -93.36M -91.34M -3.96B |
| Net Debt | 40.79M 47.25M 38.27M 34.86M 65.54M 4.52B 66.45M 449M 176M 2.26B 177M 174M 7.53B | 63.08M 73.07M 59.18M 53.9M 101M 6.99B 103M 694M 272M 3.5B 274M 268M 11.64B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/08/26 | €3.350 | +0.96% | 135,458 |
| 14/08/26 | €3.318 | -1.31% | 210,834 |
| 13/08/26 | €3.362 | +0.30% | 401,374 |
| 12/08/26 | €3.352 | +1.45% | 195,633 |
| 11/08/26 | €3.304 | +2.29% | 128,782 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSE Stock
Select your edition
All financial news and data tailored to specific country editions
